Revvity Current Ratio 2011-2025 | RVTY
Current and historical current ratio for Revvity (RVTY) from 2011 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Revvity current ratio for the three months ending September 30, 2025 was 0.00.
| Revvity Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-09-30 | $2.14B | $1.22B | 1.75 |
| 2025-06-30 | $2.24B | $0.67B | 3.33 |
| 2025-03-31 | $2.32B | $0.65B | 3.58 |
| 2024-12-31 | $2.35B | $0.65B | 3.60 |
| 2024-09-30 | $2.45B | $0.69B | 3.56 |
| 2024-06-30 | $3.16B | $1.39B | 2.27 |
| 2024-03-31 | $3.06B | $1.37B | 2.23 |
| 2023-12-31 | $3.00B | $1.45B | 2.07 |
| 2023-09-30 | $2.91B | $1.45B | 2.01 |
| 2023-06-30 | $3.52B | $1.37B | 2.58 |
| 2023-03-31 | $3.80B | $1.56B | 2.43 |
| 2022-12-31 | $3.29B | $1.54B | 2.13 |
| 2022-09-30 | $3.12B | $1.49B | 2.10 |
| 2022-06-30 | $2.11B | $1.04B | 2.02 |
| 2022-03-31 | $2.46B | $1.26B | 1.94 |
| 2021-12-31 | $2.44B | $1.21B | 2.01 |
| 2021-09-30 | $2.25B | $1.15B | 1.97 |
| 2021-06-30 | $2.26B | $1.12B | 2.01 |
| 2021-03-31 | $2.68B | $1.52B | 1.76 |
| 2020-12-31 | $2.24B | $1.65B | 1.36 |
| 2020-09-30 | $1.68B | $1.25B | 1.35 |
| 2020-06-30 | $1.53B | $1.16B | 1.32 |
| 2020-03-31 | $1.34B | $0.73B | 1.84 |
| 2019-12-31 | $1.37B | $0.76B | 1.80 |
| 2019-09-30 | $1.55B | $1.19B | 1.30 |
| 2019-06-30 | $1.34B | $0.71B | 1.89 |
| 2019-03-31 | $1.25B | $0.74B | 1.68 |
| 2018-12-31 | $1.24B | $0.77B | 1.60 |
| 2018-09-30 | $1.17B | $0.69B | 1.70 |
| 2018-06-30 | $1.20B | $0.71B | 1.69 |
| 2018-03-31 | $1.23B | $0.93B | 1.33 |
| 2017-12-31 | $1.20B | $0.95B | 1.26 |
| 2017-09-30 | $1.55B | $0.60B | 2.59 |
| 2017-06-30 | $1.43B | $0.59B | 2.43 |
| 2017-03-31 | $1.12B | $0.60B | 1.86 |
| 2016-12-31 | $1.19B | $0.60B | 1.97 |
| 2016-09-30 | $1.15B | $0.55B | 2.11 |
| 2016-06-30 | $1.08B | $0.56B | 1.92 |
| 2016-03-31 | $1.05B | $0.56B | 1.89 |
| 2015-12-31 | $1.03B | $0.56B | 1.84 |
| 2015-09-30 | $1.07B | $0.55B | 1.94 |
| 2015-06-30 | $1.07B | $0.57B | 1.86 |
| 2015-03-31 | $1.02B | $0.55B | 1.86 |
| 2014-12-31 | $1.07B | $0.60B | 1.79 |
| 2014-09-30 | $1.07B | $0.57B | 1.89 |
| 2014-06-30 | $1.08B | $0.58B | 1.87 |
| 2014-03-31 | $1.10B | $0.61B | 1.81 |
| 2013-12-31 | $1.05B | $0.60B | 1.73 |
| 2013-09-30 | $0.95B | $0.59B | 1.61 |
| 2013-06-30 | $0.91B | $0.56B | 1.61 |
| 2013-03-31 | $0.90B | $0.57B | 1.56 |
| 2012-12-31 | $0.97B | $0.58B | 1.67 |
| 2012-09-30 | $0.94B | $0.58B | 1.62 |
| 2012-06-30 | $0.90B | $0.59B | 1.53 |
| 2012-03-31 | $0.91B | $0.60B | 1.51 |
| 2011-12-31 | $0.88B | $0.60B | 1.48 |
| 2011-09-30 | $0.93B | $0.88B | 1.06 |
| 2011-06-30 | $1.08B | $0.56B | 1.92 |
| 2011-03-31 | $1.09B | $0.51B | 2.13 |
| 2010-12-31 | $1.09B | $0.52B | 2.11 |
| 2010-09-30 | $0.98B | $0.51B | 1.90 |
| 2010-06-30 | $0.92B | $0.51B | 1.80 |
| 2010-03-31 | $0.89B | $0.50B | 1.79 |
| 2009-12-31 | $0.88B | $0.50B | 1.78 |
| 2009-09-30 | $0.85B | $0.51B | 1.66 |
| 2009-06-30 | $0.82B | $0.50B | 1.65 |
| 2009-03-31 | $0.78B | $0.47B | 1.67 |
| 2008-12-31 | $0.83B | $0.52B | 1.61 |
| 2008-09-30 | $0.87B | $0.52B | 1.66 |
| 2008-06-30 | $0.88B | $0.57B | 1.55 |
| 2008-03-31 | $0.88B | $0.56B | 1.57 |
| 2007-12-31 | $0.84B | $0.55B | 1.54 |
| 2007-09-30 | $0.76B | $0.45B | 1.70 |
| 2007-06-30 | $0.71B | $0.45B | 1.58 |
| 2007-03-31 | $0.68B | $0.42B | 1.60 |
| 2006-12-31 | $0.75B | $0.48B | 1.56 |
| 2006-09-30 | $0.72B | $0.43B | 1.66 |
| 2006-06-30 | $0.81B | $0.42B | 1.93 |
| 2006-03-31 | $0.80B | $0.40B | 2.00 |
| 2005-12-31 | $1.00B | $0.50B | 2.02 |
| 2005-09-30 | $0.71B | $0.44B | 1.60 |
| 2005-06-30 | $0.70B | $0.47B | 1.48 |
| 2005-03-31 | $0.74B | $0.43B | 1.71 |
| 2004-12-31 | $0.75B | $0.45B | 1.68 |
| 2004-09-30 | $0.78B | $0.44B | 1.76 |
| 2004-06-30 | $0.76B | $0.44B | 1.72 |
| 2004-03-31 | $0.75B | $0.45B | 1.67 |
| 2003-12-31 | $0.77B | $0.45B | 1.70 |
| 2003-09-30 | $0.77B | $0.45B | 1.73 |
| 2003-06-30 | $0.94B | $0.62B | 1.51 |
| 2003-03-31 | $0.93B | $0.63B | 1.48 |
| 2002-12-31 | $0.99B | $0.68B | 1.44 |
| 2002-09-30 | $0.79B | $0.67B | 1.18 |
| 2002-06-30 | $0.86B | $0.60B | 1.44 |
| 2002-03-31 | $1.01B | $0.72B | 1.41 |
| 2001-12-31 | $0.94B | $0.76B | 1.25 |
| 2001-09-30 | $1.02B | $0.63B | 1.62 |
| 2001-06-30 | $0.96B | $0.68B | 1.41 |
| 2001-03-31 | $0.95B | $0.73B | 1.31 |
| 2000-12-31 | $0.93B | $0.65B | 1.43 |
| 2000-09-30 | $0.89B | $0.80B | 1.11 |
| 2000-06-30 | $0.82B | $0.81B | 1.02 |
| 2000-03-31 | $0.82B | $0.78B | 1.04 |
| 1999-12-31 | $0.82B | $0.85B | 0.96 |
| 1999-09-30 | $0.73B | $0.85B | 0.86 |
| 1999-06-30 | $0.72B | $0.97B | 0.74 |
| 1999-03-31 | $0.57B | $0.53B | 1.08 |
| 1998-12-31 | $0.57B | $0.52B | 1.08 |
| 1998-09-30 | $0.56B | $0.33B | 1.71 |
| 1998-06-30 | $0.57B | $0.32B | 1.78 |
| 1998-03-31 | $0.53B | $0.30B | 1.79 |
| 1997-12-31 | $0.49B | $0.29B | 1.71 |
| 1997-09-30 | $0.47B | $0.28B | 1.70 |
| 1997-06-30 | $0.48B | $0.30B | 1.57 |
| 1997-03-31 | $0.45B | $0.26B | 1.70 |
| 1996-12-31 | $0.46B | $0.26B | 1.75 |
| 1996-09-30 | $0.48B | $0.27B | 1.74 |
| 1996-06-30 | $0.49B | $0.29B | 1.69 |
| 1996-03-31 | $0.48B | $0.28B | 1.74 |
| 1995-12-31 | $0.47B | $0.25B | 1.87 |
| 1995-09-30 | $0.44B | $0.36B | 1.25 |
| 1995-06-30 | $0.45B | $0.28B | 1.62 |
| 1995-03-31 | $0.48B | $0.30B | 1.59 |
| 1994-12-31 | $0.48B | $0.28B | 1.71 |
| 1994-09-30 | $0.47B | $0.28B | 1.68 |
| 1994-06-30 | $0.46B | $0.25B | 1.89 |
| 1994-03-31 | $0.46B | $0.25B | 1.86 |
| 1993-12-31 | $0.47B | $0.24B | 1.96 |
| 1993-09-30 | $0.48B | $0.25B | 1.88 |
| 1993-06-30 | $0.49B | $0.28B | 1.76 |
| 1993-03-31 | $0.47B | $0.24B | 2.02 |
| 1992-12-31 | $0.48B | $0.24B | 2.05 |
| 1992-09-30 | $0.47B | $0.25B | 1.87 |
| 1992-06-30 | $0.47B | $0.27B | 1.73 |
| 1992-03-31 | $0.49B | $0.26B | 1.86 |
| 1991-12-31 | $0.46B | $0.24B | 1.89 |
| 1991-09-30 | $0.43B | $0.25B | 1.73 |
| 1991-06-30 | $0.42B | $0.26B | 1.64 |
| 1991-03-31 | $0.43B | $0.27B | 1.59 |
| 1990-12-31 | $0.41B | $0.26B | 1.58 |
| 1990-09-30 | $0.42B | $0.27B | 1.56 |
| 1990-06-30 | $0.41B | $0.25B | 1.64 |
| 1990-03-31 | $0.40B | $0.24B | 1.65 |
| 1989-12-31 | $0.41B | $0.26B | 1.59 |
| 1989-09-30 | $0.39B | $0.21B | 1.87 |
| 1989-06-30 | $0.37B | $0.20B | 1.92 |
| 1989-03-31 | $0.39B | $0.20B | 1.92 |
| 1988-12-31 | $0.36B | $0.17B | 2.10 |
| 1988-09-30 | $0.32B | $0.18B | 1.80 |
| 1988-06-30 | $0.31B | $0.20B | 1.56 |
| 1988-03-31 | $0.32B | $0.20B | 1.58 |
| 1987-12-31 | $0.32B | $0.21B | 1.56 |
| 1987-09-30 | $0.29B | $0.18B | 1.64 |
| 1987-06-30 | $0.29B | $0.19B | 1.58 |
| 1987-03-31 | $0.27B | $0.17B | 1.63 |
| 1986-12-31 | $0.27B | $0.17B | 1.61 |
| 1985-12-31 | $0.27B | $0.18B | 1.46 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.672B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $154.973B | 28.46 |
| HCA Healthcare (HCA) | United States | $108.075B | 17.89 |
| CVS Health (CVS) | United States | $101.885B | 11.72 |
| Elevance Health (ELV) | United States | $72.812B | 10.68 |
| Cencora (COR) | United States | $70.459B | 22.73 |
| Natera (NTRA) | United States | $28.914B | 0.00 |
| DiDi Global (DIDIY) | China | $26.262B | 21.46 |
| Labcorp Holdings (LH) | United States | $22.051B | 16.81 |
| Medpace Holdings (MEDP) | United States | $16.833B | 41.79 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| ICON (ICLR) | Ireland | $13.197B | 13.10 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.005B | 0.00 |
| Solventum (SOLV) | United States | $12.806B | 12.43 |
| Viatris (VTRS) | United States | $12.681B | 4.73 |
| CochLear (CHEOY) | Australia | $12.223B | 0.00 |
| HealthEquity (HQY) | United States | $8.659B | 34.65 |
| Charles River Laboratories (CRL) | United States | $8.440B | 16.26 |
| Avantor (AVTR) | United States | $7.875B | 12.03 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.989B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.969B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $6.067B | 36.17 |
| Bausch + Lomb (BLCO) | Canada | $5.880B | 38.60 |
| Sotera Health (SHC) | United States | $4.617B | 22.26 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $3.944B | 69.26 |
| Alignment Healthcare (ALHC) | United States | $3.322B | 0.00 |
| Concentras Parent (CON) | United States | $2.558B | 15.97 |
| Premier (PINC) | United States | $2.326B | 22.54 |
| Progyny (PGNY) | United States | $2.075B | 40.80 |
| Surgery Partners (SGRY) | United States | $2.051B | 26.43 |
| Ardent Health (ARDT) | United States | $2.011B | 6.57 |
| Organon (OGN) | United States | $2.004B | 2.11 |
| Pediatrix Medical (MD) | United States | $1.949B | 11.64 |
| Establishment Labs Holdings (ESTA) | $1.836B | 0.00 | |
| PACS (PACS) | United States | $1.747B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.326B | 0.00 |
| Omada Health (OMDA) | $1.242B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.063B | 17.00 |
| Embecta (EMBC) | United States | $0.848B | 4.97 |
| CareDx (CDNA) | United States | $0.839B | 13.71 |
| InnovAge Holding (INNV) | United States | $0.772B | 0.00 |
| Nutex Health (NUTX) | United States | $0.676B | 10.23 |
| AMN Healthcare Services Inc (AMN) | United States | $0.637B | 8.78 |
| Sonida Senior Living (SNDA) | United States | $0.602B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.562B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Pomdoctor - (POM) | China | $0.457B | 0.00 |
| CryoPort (CYRX) | United States | $0.442B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.417B | 0.00 |
| Enhabit (EHAB) | United States | $0.407B | 18.30 |
| Auna S.A (AUNA) | Luxembourg | $0.387B | 5.81 |
| So-Young (SY) | China | $0.378B | 0.00 |
| SBC Medicals (SBC) | United States | $0.351B | 7.68 |
| Oncology Institute (TOI) | United States | $0.321B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.305B | 0.00 |
| KindlyMD (NAKA) | United States | $0.295B | 0.00 |
| Agilon Health (AGL) | United States | $0.260B | 0.00 |
| LifeMD (LFMD) | United States | $0.240B | 0.00 |
| Beauty Health (SKIN) | United States | $0.169B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 26.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.137B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.118B | 0.00 |
| DocGo (DCGO) | United States | $0.106B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.026B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.024B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 5.58 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |